Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI guide novices to capture clear heart images?

NCT ID NCT07771270

Knowledge-focused Sponsor: EchoNous Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This study evaluates an AI system designed to help people with little ultrasound experience capture clear images of the heart. Researchers will review previously recorded ultrasound clips to see if the system's on-screen guidance correctly corrects the probe position and whether its auto-capture feature grabs diagnostic-quality images. The goal is to measure how often the AI's suggestions lead to better views and whether the captured clips meet clinical standards.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Kosmos Trio Guidance algorithm and Auto-Capture feature (software algorithms for cardiac ultrasound)
What this could lead to
If successful, this could validate AI-driven guidance that helps non-experts obtain high-quality cardiac ultrasound images, potentially expanding access to heart imaging.
What could go wrong
This is a retrospective analysis of existing clips, not a live trial, and success depends on expert reviewers' subjective ratings. The algorithm may not perform consistently across all heart views or in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 81 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study used retrospective datasets from 2 sources: ECHO-020 Kosmos Guidance, Grading, and Capture Performance Evaluation study, and ECHO-025 Kosmos Guidance Performance Evaluation study. Both datasets comprise fully de-identified, retrospective, echocardiographic clips acquired using the Kosmos diagnostic ultrasound system. Data collection for both studies was performed at EchoNous headquarters in Redmond, Washington. Source data was collected targeting a balanced representation of demographics and clinical characteristics (including gender and BMI) to ensure the generalizability of study findings.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All data used in this study must have been collected per 45 CFR § 26, * Data must have been collected per source protocol requirements with no deviation for that data set, * Adequate demographic information available from original study participation (sex, BMI, ethnicity, and race) * Exam acquisition performed by a qualified echocardiographer using the Kosmos system Exclusion Criteria: * Inadequate demographic information corresponding to the available data, and * Non-echocardiographer acquired images.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac disease Cardiac ultrasound HEART Ultrasound

Contacts and locations

Locations

  • EchoNous, Inc.

    Redmond, Washington, 98052, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.